"On behalf of the 35 patient, physician, and research organizations that are members of the Friends of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), we want first to thank you for your ongoing bipartisan investment in the National Institutes of Health (NIH). We ask you to support our FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIH’s base budget to keep pace with the biomedical research and development price index of 2.3 % and allow meaningful growth of 5%. We also request a proportionate increase for the NIDDK of at least $157 million for a total of $2.289 billion in FY 2022. This level of increase over its FY 2021 funding is necessary for NIDDK to fulfill its mission to conduct and support medical research, research training, and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases and to support the Institute’s multi-pronged efforts toward the goal of health equity. We also strongly encourage you to provide supplemental emergency funding of $10 billion for NIH, ensure dedicated support for the NIDDK to enable critical COVID-related research, and support research recovery from the impact of the pandemic."
Read the Full Testimony
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.